Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Long-Term Debt Issuances (2012 - 2023)

Updated

Analysis

Dr Reddys Laboratories (RDY) Long-Term Debt Issuances (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 9.98 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 46.25 Mn
Jun 30, 2020 49.97 Mn
Mar 31, 2018 1.46 Mn
Dec 31, 2017 -1.47 Mn
Jun 30, 2017 295.72 Mn
Mar 31, 2017 89,609.49
Dec 31, 2016 -76.75 Mn
Sep 30, 2016 -403,387.83
Jun 30, 2016 -418,840.00
Jun 30, 2013 -35.00 Mn
Jun 30, 2012 6.00 Mn
API Access

Dr Reddys Laboratories Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RDY&period=max&api_key=YOUR_API_KEY